Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
29 hedge funds and large institutions have $5.05M invested in Pernix Therapeutics Holdings, Inc. in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 5 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
4% more capital invested
Capital invested by funds: $4.85M → $5.05M (+$196K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less funds holding
Funds holding: 33 → 29 (-4)
42% less call options, than puts
Call options by funds: $143K | Put options by funds: $247K
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$147K |
| 2 |
BlackRock
New York
|
+$31.5K |
| 3 |
Renaissance Technologies
New York
|
+$30.6K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$29.4K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$18.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$111K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$37K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$16K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.67K |
| 5 |
SAMH
Shanda Asset Management Holdings
Tortola,,
British Virgin Islands
|
-$2K |
PTX Hedge Fund Activity: Q2 2018 in Review
29 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q2 2018, worth a combined $5.05M — up 4% from $4.85M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PTX and 1 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 10 added.
The largest buyer was Bank of Montreal, adding an estimated $147K. The largest seller was Virtu Financial, exiting entirely with an estimated $111K sold.
- 29 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q2 2018, down from 33 in Q1 2018.
- Funds reported $5.05M of Pernix Therapeutics Holdings, Inc. stock for Q2 2018, up 4% quarter-over-quarter.
- 1 fund opened new Pernix Therapeutics Holdings, Inc. positions in Q2 2018 and 5 closed out, a net change of -4 holders.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q2 2018 was Bank of Montreal, an estimated $147K added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q2 2018 was Virtu Financial, an estimated $111K sold.
Based on aggregated 13F filings for Q2 2018.